Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
4.543
-0.047 (-1.02%)
At close: Apr 28, 2026, 4:00 PM EDT
4.320
-0.223 (-4.92%)
After-hours: Apr 28, 2026, 7:17 PM EDT

Purple Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-26.39-7.24-19.88-21.67-18.38
Upgrade
Depreciation & Amortization
0.20.190.20.20.23
Upgrade
Asset Writedown & Restructuring Costs
20.480.2---
Upgrade
Stock-Based Compensation
0.310.581.882.412.08
Upgrade
Other Operating Activities
-1.07-3.77-2.39-0.940.45
Upgrade
Change in Accounts Payable
0.45-2.081.330.80.4
Upgrade
Change in Other Net Operating Assets
0.36-2.26-1.062.460.35
Upgrade
Operating Cash Flow
-5.66-14.37-19.93-16.74-15.25
Upgrade
Capital Expenditures
-0--0-0.03-0.12
Upgrade
Cash Acquisitions
---3.55--
Upgrade
Sale (Purchase) of Intangibles
----0.2-
Upgrade
Investment in Securities
0.450.1916.6819.6610.25
Upgrade
Other Investing Activities
0.190.320.760.483.27
Upgrade
Investing Cash Flow
0.630.5113.8819.9113.41
Upgrade
Long-Term Debt Repaid
-0.22-0.18-0.17-0.17-0.15
Upgrade
Total Debt Repaid
-0.22-0.18-0.17-0.17-0.15
Upgrade
Net Debt Issued (Repaid)
-0.22-0.18-0.17-0.17-0.15
Upgrade
Issuance of Common Stock
3.157.841.561.51.76
Upgrade
Other Financing Activities
3.4-0.884.05-0.22-0.1
Upgrade
Financing Cash Flow
6.336.775.451.111.51
Upgrade
Foreign Exchange Rate Adjustments
0.01-00.05-0.15-0.02
Upgrade
Net Cash Flow
1.32-7.09-0.544.14-0.36
Upgrade
Free Cash Flow
-5.66-14.37-19.93-16.76-15.37
Upgrade
Free Cash Flow Per Share
-0.01-0.04-0.09-0.09-0.09
Upgrade
Cash Interest Paid
0.020.040.060.070.08
Upgrade
Levered Free Cash Flow
-0.05-11.7-8.43-8.8-7.64
Upgrade
Unlevered Free Cash Flow
-0.05-11.7-8.43-8.8-7.64
Upgrade
Change in Working Capital
0.81-4.330.273.260.74
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.